Antiangiogenic-induced hypertension: the molecular basis of signaling network (Q37973600)

26 August 2017

Antiangiogenic-induced hypertension: the molecular basis of signaling network (English)

1 reference

26 August 2017

arterial hypertension

0 references

angiogenesis inhibitor

1 reference

9

Hiroshi Kobayashi

1 reference

26 August 2017

Akira Nagai

1

1 reference

26 August 2017

Toshiyuki Sado

2

1 reference

26 August 2017

Katsuhiko Naruse

3

1 reference

26 August 2017

Taketoshi Noguchi

4

1 reference

26 August 2017

Shoji Haruta

5

1 reference

26 August 2017

Shozo Yoshida

6

1 reference

26 August 2017

Yasuhito Tanase

7

1 reference

26 August 2017

Taihei Tsunemi

8

1 reference

26 August 2017

language of work or name

1 reference

3 January 2012

1 reference

Gynecologic and Obstetric Investigation

26 August 2017

1 reference

26 August 2017

73

1 reference

26 August 2017

2

1 reference

26 August 2017

89-98

1 reference

Circulating and Vascular Bioactive Factors during Hypertension in Pregnancy

26 August 2017

1 reference

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

21 January 2018

1 reference

Potential role of soluble VEGFR-1 in antiangiogenesis therapy for cancer

21 January 2018

1 reference

Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies.

21 January 2018

1 reference

Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset pre-eclampsia.

21 January 2018

1 reference

Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction

21 January 2018

1 reference

Blood pressure rise following angiogenesis inhibition by bevacizumab. A crucial role for microcirculation

21 January 2018

1 reference

Suppression of the nitric oxide pathway in metastatic renal cell carcinoma patients receiving vascular endothelial growth factor-signaling inhibitors

21 January 2018

1 reference

Bevacizumab-induced hypertension: pathogenesis and management

21 January 2018

1 reference

Vasodilator factors in the systemic and local adaptations to pregnancy.

21 January 2018

1 reference

Endothelial effects of antihypertensive treatment: focus on irbesartan

21 January 2018

1 reference

The multiple actions of NO.

21 January 2018

1 reference

Nitric oxide and neuronal death

21 January 2018

1 reference

Role of the prostanoid EP4 receptor in iloprost-mediated vasodilatation in pulmonary hypertension

21 January 2018

1 reference

Smooth muscle proliferation and role of the prostacyclin (IP) receptor in idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

Shear stress induces synthetic-to-contractile phenotypic modulation in smooth muscle cells via peroxisome proliferator-activated receptor alpha/delta activations by prostacyclin released by sheared endothelial cells

21 January 2018

1 reference

AT(2) receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditions

21 January 2018

1 reference

Tissue kallikrein in human placenta in early and late gestation

21 January 2018

1 reference

Activation of PAR-2 elicits NO-dependent and CGRP-independent dilation of the dural artery

21 January 2018

1 reference

Defects in cutaneous angiotensin-converting enzyme 2 and angiotensin-(1-7) production in postural tachycardia syndrome

21 January 2018

1 reference

Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis.

21 January 2018

1 reference

Relaxin as a natural agent for vascular health

21 January 2018

1 reference

Intrauterine pulmonary hypertension impairs angiogenesis in vitro: role of vascular endothelial growth factor nitric oxide signaling

21 January 2018

1 reference

Src-mediated phosphorylation of Hsp90 in response to vascular endothelial growth factor (VEGF) is required for VEGF receptor-2 signaling to endothelial NO synthase.

21 January 2018

1 reference

An ezrin/calpain/PI3K/AMPK/eNOSs1179 signaling cascade mediating VEGF-dependent endothelial nitric oxide production

21 January 2018

1 reference

Vascular endothelial growth factor receptor 2 controls blood pressure by regulating nitric oxide synthase expression

21 January 2018

1 reference

Vascular endothelial growth factor: basic science and clinical progress

21 January 2018

1 reference

Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis

21 January 2018

1 reference

The effect of hypertension on serum nitric oxide and vascular endothelial growth factor concentrations. A study in DOCA-Salt hypertensive ovariectomized rats.

21 January 2018

1 reference

Vascular endothelial growth factors and vascular permeability

21 January 2018

1 reference

Soluble FLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizing VEGF receptor-mediated signalling

21 January 2018

1 reference

Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation

21 January 2018

1 reference

m-Calpain activation is regulated by its membrane localization and by its binding to phosphatidylinositol 4,5-bisphosphate.

21 January 2018

1 reference

Helicobacter pylori VacA disrupts apical membrane-cytoskeletal interactions in gastric parietal cells

21 January 2018

1 reference

Calpain-2 regulation of VEGF-mediated angiogenesis

21 January 2018

1 reference

Vascular endothelial growth factor stimulates a novel calcium-signaling pathway in vascular smooth muscle cells

21 January 2018

1 reference

CaMKK-CaMKI signaling pathways differentially control axon and dendrite elongation in cortical neurons.

21 January 2018

1 reference

Activation of AMP-activated protein kinase by vascular endothelial growth factor mediates endothelial angiogenesis independently of nitric-oxide synthase

21 January 2018

1 reference

AMP-activated protein kinase control of fat metabolism in skeletal muscle

21 January 2018

1 reference

The role of AMP-activated protein kinase in the functional effects of vascular endothelial growth factor-A and -B in human aortic endothelial cells.

21 January 2018

1 reference

Endothelium-dependent vasorelaxation to the AMPK activator AICAR is enhanced in aorta from hypertensive rats and is NO and EDCF dependent.

21 January 2018

1 reference

Agonist-modulated regulation of AMP-activated protein kinase (AMPK) in endothelial cells. Evidence for an AMPK -> Rac1 -> Akt -> endothelial nitric-oxide synthase pathway.

21 January 2018

1 reference

Uncoupling of vascular endothelial growth factor with nitric oxide as a mechanism for diabetic vasculopathy

21 January 2018

1 reference

Differential regulation of VEGF signaling by PKC-alpha and PKC-epsilon in endothelial cells

21 January 2018

1 reference

Driving Rho GTPase activity in endothelial cells regulates barrier integrity.

21 January 2018

1 reference

Rac1-dependent intracellular superoxide formation mediates vascular endothelial growth factor-induced placental angiogenesis in vitro

21 January 2018

1 reference

NADPH oxidase 4 mediates reactive oxygen species induction of CD146 dimerization in VEGF signal transduction.

21 January 2018

1 reference

Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy

21 January 2018

1 reference

Pathophysiological roles of NADPH oxidase/nox family proteins in the vascular system. -Review and perspective-.

21 January 2018

1 reference

The role of vascular endothelial growth factor-induced activation of NADPH oxidase in choroidal endothelial cells and choroidal neovascularization

21 January 2018

1 reference

Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability

21 January 2018

1 reference

FHL-2 suppresses VEGF-induced phosphatidylinositol 3-kinase/Akt activation via interaction with sphingosine kinase-1.

21 January 2018

1 reference

Nitric oxide and adverse events of vascular endothelial growth factor inhibitors

21 January 2018

1 reference

Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis

21 January 2018

1 reference

Role of phosphodiesterase 5 in synaptic plasticity and memory

21 January 2018

1 reference

Hypothesis: selective phosphodiesterase-5 inhibition improves outcome in preeclampsia

21 January 2018

1 reference

The effect of sildenafil on the altered thoracic aorta smooth muscle responses in rat pre-eclampsia model

21 January 2018

1 reference

Effects of a phosphodiesterase-5 (PDE5) inhibitor on endothelium-dependent relaxation of myometrial small arteries

21 January 2018

1 reference

A randomised, double-blinded, placebo-controlled study of the phosphodiesterase type 5 inhibitor sildenafil for the treatment of preeclampsia

21 January 2018

1 reference

Vasoactive and permeability effects of vascular endothelial growth factor-165 in the term in vitro dually perfused human placental lobule.

21 January 2018

1 reference

Phosphodiesterase-5 inhibitors and omental and placental small artery function in normal pregnancy and pre-eclampsia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000334458

1 reference

26 August 2017

1 reference